RxDoctor Payments Data

Robert Meyer

Internal Medicine · Orlando, FLNPI 1265465009

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,503 of the $3,290 with a category attached, or 76.1%. 3 manufacturers reported payments, led by Eli Lilly at 48.2% of the total.

$3,290in general payments, 2019–2025

Across 26 payments — averaging $126.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Eisai Inc.$2K
  • Madrigal Pharmaceuticals$150
$2,272,216in research payments, 2019–2025

Across 669 payments — averaging $3396.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$813K
  • Eisai Inc.$477K
  • Biogen$342K
  • Sanofi Pasteur Inc.$298K
  • Astrazeneca UK Limited$163K
  • Vertex$92K
  • plus $87K from 3 others

What the payments were for

  • Travel & lodging$2,50376%
  • Food & beverage$78624%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly11$1,587
Eisai Inc.14$1,553
Madrigal Pharmaceuticals1$150

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,290 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →